Are you Dr. Cukras?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10C438 Rockville Pike
"# 10"
Bethesda, MD 20892Phone+1 301-435-5061
Summary
- Dr. Catherine Cukras, MD is a board certified ophthalmologist in Bethesda, Maryland. She is currently licensed to practice medicine in Pennsylvania and Pennsylvania.
Certifications & Licensure
PA State Medical License 2007 - 2026- PA State Medical License 2003 - 2024
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT Imaging.Kenta Yoshida, Neha Anegondi, Adam Pely, Miao Zhang, Frederic Debraine
Translational Vision Science & Technology. 2025-02-03 - Automated Detection of Drusenoid Pigment Epithelial Detachments From Spectral-Domain Optical Coherence Tomography in Patients With AMD.Souvick Mukherjee, Cameron Duic, Tharindu De Silva, Tiarnan D L Keenan, Alisa T Thavikulwat
Translational Vision Science & Technology. 2024-11-04 - Biallelic Loss-of-Function Variants in UBAP1L and Nonsyndromic Retinal Dystrophies.Ehsan Ullah, Siying Lin, Jiaxiong Lu, Chelsea Bender, Andrew R Webster
JAMA Ophthalmology. 2024-11-01
Press Mentions
New Treatments for Macular Degeneration Are on the WayJune 8th, 2020
NIH Adds Eight Lasker Clinical Research ScholarsMarch 12th, 2019
Grant Support
- An Investigation of Vitamin A Palmitate Supplementation in Patients withAMD and/or Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationNATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
- Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity,NATIONAL EYE INSTITUTEPresent
- An Investigation of Vitamin A Palmitate Supplementation in Patients withAMD and/or Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationNATIONAL EYE INSTITUTEPresent
- Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated with Retinitis PigmentosaNATIONAL EYE INSTITUTEPresent
- Longitudinal Investigation of Dark Adaptation in Participants with AMDNATIONAL EYE INSTITUTEPresent
- A Survey study of Retinitis Pigmentosa (RP) clinical measures and repeatability testing of potential outcome measuresNATIONAL EYE INSTITUTEPresent
- Adaptive Optics Imaging of Outer Retinal DiseasesNATIONAL EYE INSTITUTEPresent
- A Survey study of Retinitis Pigmentosa (RP) clinical measures and repeatability testing of potential outcome measuresNATIONAL EYE INSTITUTEPresent
- Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated with Retinitis PigmentosaNATIONAL EYE INSTITUTEPresent
- Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity,NATIONAL EYE INSTITUTEPresent
- Longitudinal Investigation of Dark Adaptation in Participants with AMDNATIONAL EYE INSTITUTEPresent
- Medical Retina FellowshipNATIONAL EYE INSTITUTEPresent
- Adaptive Optics Imaging of Outer Retinal DiseasesNATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
- Eval. of Minocycline as a Microglia Inhibitor in Tx of CRVO and BRVONATIONAL EYE INSTITUTEPresent
